Invasive zygomycosis in patients with graft‐versus‐host disease after allogeneic stem cell transplantation
暂无分享,去创建一个
C. Junghanss | F. Prall | M. Freund | M. Maruschke | D. Wolff | I. Hilgendorf | C. Kahl | C. Aepinus | H. Riemer | K. Jost | M. Leithauser
[1] Y. Taur,et al. Risk factors and attributable mortality of late aspergillosis after T‐cell depleted hematopoietic stem cell transplantation , 2008, Transplant infectious disease : an official journal of the Transplantation Society.
[2] M. Sorror,et al. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens , 2008, Bone Marrow Transplantation.
[3] L. Gordon,et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole , 2007, Bone Marrow Transplantation.
[4] T. Berney,et al. Invasive zygomycosis in transplant recipients , 2007, Clinical transplantation.
[5] M. Rinaldi,et al. In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents , 2007, Antimicrobial Agents and Chemotherapy.
[6] J. Mehta,et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy , 2007, Bone Marrow Transplantation.
[7] M. Boeckh,et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] J. Lipton,et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.
[9] C. Romano,et al. Primary subcutaneous zygomycosis due to Rhizopus oryzae in a 71‐year‐old man with normal immune status , 2007, Mycoses (Berlin).
[10] V. Rickerts,et al. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia , 2006, Mycoses.
[11] O. Cornely,et al. [Zygomycosis after hematogeneic stem cell transplantation--a current problem?]. , 2006, Medizinische Klinik.
[12] D. Kontoyiannis,et al. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] M. Schuster,et al. Posaconazole as Salvage Therapy for Zygomycosis , 2006, Antimicrobial Agents and Chemotherapy.
[14] R. Foà,et al. Breakthrough Candida krusei Fungemia during Fluconazole Prophylaxis followed by Breakthrough Zygomycosis during Caspofungin Therapy in a Patient with Severe Aplastic Anemia Who Underwent Stem Cell Transplantation , 2005, Journal of Clinical Microbiology.
[15] R. Jain,et al. Disseminated zygomycosis post allogeneic bone marrow transplantation , 2005, American journal of hematology/oncology.
[16] Russell E. Lewis,et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.
[17] P. Chevallier,et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] M. Czuczman,et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics , 2005, Mycopathologia.
[19] A. Safdar,et al. Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis , 2004, Bone Marrow Transplantation.
[20] J. Englund,et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] L. Bartelt,et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] J. Robson,et al. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis , 2004, Mycoses.
[23] F. Marty,et al. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. , 2004, The New England journal of medicine.
[24] M. Maris,et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. , 2003, Blood.
[25] Lawrence Corey,et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Y. Senda,et al. Multiplex PCR Using Internal Transcribed Spacer 1 and 2 Regions for Rapid Detection and Identification of Yeast Strains , 2001, Journal of Clinical Microbiology.
[27] E. Anaissie,et al. Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[28] G. Verhoef,et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis , 1999, Bone Marrow Transplantation.
[29] M. Vidaud,et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR , 1995, Journal of clinical microbiology.
[30] T. White. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .